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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S295ĂConclusion: The effectiveness of HA injections for the treatment of
patients with knee OA remains unclear. Some researchers reported that
the volume of SF and the molecular weight of C4S, C6S and KS decreased,
and themolecular weight of HA increased after ﬁveweekly injections. Also
they reported that clinical symptoms improved after HA injections. Our
results showed that the ROM improved with the decrease of SF after ﬁve
weekly injection. The destruction of proteoglycan in articular cartilage
resulted in the decrease of the molecular weight of C4S, C6S, and KS.
However, our results showed that molecular weight of HA, C4S, C6S and KS
before HA injection did not change after HA injection. A possible reason of
the difference between previous and this studies might be related with the
small number of this study. In summary, our study showed that clinical
symptoms and ROM improved with the decrease of effusion, although the
destructive products of cartilage did not change after ﬁve weekly HA
injections. In future, we should enrolled many patients with knee OA and
investigate the relationship between the proceeding of knee OA and the
destructive products of cartilage.
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DESIGN RATIONALE AND EARLY CLINICAL / SURGICAL OBSERVATIONS
WITH A TISSUE SPARING STEM FOR THA IN OSTEOARTHRITIS
T. McTighe 1, D. Brazil 2. The TSI Study Group1 Joint Implant Surgery and
Res. Fndn., Chagrin Falls, OH, USA; 2 Joint Implant Surgery and Res. Fndn.,
Sydney, Australia
Abstract: Architectural changes occurring in the proximal femur after
THA continues to be a problem. Proximal stress shielding occurs
regardless of ﬁxation method. The resultant bone loss can lead to implant
loosening and or breakage of the implant. We are seeing younger
patients with higher levels of physical activity as compared to just
a decade ago. A tissue sparing total hip stem provides for less tissue
damage, a quicker rehab and leaves behind more infrastructure in case of
future revision surgery.
Introduction: Patients today demand more out of the hip recon-
struction and their increase activity places a higher demand on the
implant. A number of the current short stems introduced into the
market are no more than standard stems cut short. There is concern
with the increase in younger and more active patients that these
modiﬁed short stems be adequate to resist the increased biome-
chanical loads placed on them?
The purpose of this paper is to review a new novel neck sparing total hip
stem and the method by which this stem achieves implant/bone stability,
surgical technique required, and observations as to early clinical outcomes.
Material: There have been 750 stems implanted with this novel neck
sparing stem design since April 2010 with 600 from the surgical team
(seven) posted for review. . All seven were part of the initial surgical team
to aid in designing and ﬁne-tuning of surgical instruments. Typical patient
proﬁle showed two-thirds being female with an age range overall between
17 to early 90s. 90%were treated for OA. This stem has been used in all Dorr
bone classiﬁcations (A, B, &C). Two surgical approaches were utilized the
single anterior incision and standard posterior incision.
Results: Anterior Approach Dislocations ¼ 2 Stem Revisions ¼ 3 Aseptic
Loosening ¼ 1 Superﬁcial Infection ¼ 2 Septic Loosening ¼ 0 Leg / Length
Discrepancy +/- 7 mm ¼ 9 / 0.3% Occult fracture distal end of stem ¼ 1
Calcar Fractures wired ¼ 2 Calcar Fractures not wired ¼ 3 Hip pain ¼ 1
Subsidence > 5mm ¼ 3 Intra-op femoral perforation ¼ 3 Intra-op calcar
fractures resulting in stem bailout ¼ 0 Posterior Approach Dislocations¼ 2
Stem Revisions ¼ 1 Aseptic Loosening ¼ 0 Septic Loosening ¼ 1 Superﬁcial
Infection¼ 0 Leg / length Discrepancy +/- 7 mm¼ 3 / .013% Fractures distal
¼ 0 Calcar Cracks wired ¼ 0 Calcar Cracks not wired ¼ 1 Hip pain ¼ 1(process of being worked up/ potential spine problem) Subsidence > 5mm
¼ 0 Intra-op calcar fractures resulting in stem bailout ¼ 2
Discussion: There is a short learning curve for the surgeon (2-3 cases)
and an easy transition for the O.R. surgical team with only one pan of
instruments. Six of the seven surgeons feel that these patients with this
short curved neck-sparing stem have gotten back to full weight bearing
and a full active life style quicker than their conventional cementless
THA. One surgeon gauges them as equivalent to his conventional stems.
All feel that there is less blood loss and operative times have been
reduced.
The few explants have proven to be easily converted to a primary stem for
revisions. Two intra-operative calcar fractures resulted in a bail out to
a conventional primary cementless stem. The modular neck has proven to
be beneﬁcial in a couple of cases for access to the socket in revision situ-
ations. The modularity of the neck also helps reducing risk of mechanical
impingement.
There have been minor incidence of over lengthening the leg (11) greater
than 7 mm however; none have had to be revised.
We are encouragedwith our initial clinical / surgical observations (patients
are happy) and believe the potential and real beneﬁts warrant not only
further evaluation but expanded evaluation of this tissue conserving
approach to THA.
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INTRA-ARTICULAR GROWTH HORMONE INJECTIONS REGROW
CARTILAGE, INCREASE MOTION AND REDUCE PAIN IN 93 PER CENT.
OF ARTHRITIC ANKLES.
A.R. Dunn. Mt. Sinai Med. Ctr., Miami Beach Florida, FL, USA
Purpose: Purpose: The author uses intra-articular growth hormone(iagh)
injections as a treatment for osteoarthritis(OA) of the ankle. Results of this
treatment were ﬁrst observed in the author's studies of cartilage healing
following intra-articular growth hormone(IAGH) injections in surgically
debrided knees in mature rabbits. Iagh causes Pre-natal Developmental
Healing(PDH) of cartilage which grows fetal cartilage by recapitulation of
the cascades of development. PDH involves no inﬂammation and produces
no scar tissue. The method was translated to the iagh treatment of 14
patients with advanced OA of the ankle. Age ranged from 37 to 76 years.
There were 10 males and 4 females followed 2 to 4 years post treatment.
Iagh treatment has no side effects, complications, infections, or deaths.
